blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1767229

EP1767229 - Expanded PTFE drug delivery graft [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.06.2018
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  14.07.2017
FormerGrant of patent is intended
Status updated on  04.04.2017
Most recent event   Tooltip22.06.2018No opposition filed within time limitpublished on 25.07.2018  [2018/30]
Applicant(s)For:DE  ES  FR  GB 
Bard Peripheral Vascular, Inc.
1415 West 3rd Street
Suite 109
P.O. Box 1740
Tempe, AZ 85280-1740 / US
[2017/33]
Former [2012/14]For:DE  ES  FR  GB 
Bard Peripheral Vascular, Inc.
1415 West 3rd Street, Suite 109 P.O. Box 1740
Tempe, AZ 85280-1740 / US
Former [2010/25]For:BE  DE  ES  FR  GB  IT 
Bard Peripheral Vascular, Inc.
1415 West 3rd Street, Suite 109 P.O. Box 1740
Tempe, AZ 85280-1740 / US
Former [2007/13]For all designated states
Bard Peripheral Vascular, Inc.
1415 West 3rd Street, Suite 109 P.O. Box 1740
Tempe, AZ 85280-1740 / US
Inventor(s)01 / Calcote, Robert
23959 SE 41st Place
Issaquah, WA 98029 / US
 [2007/13]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2017/33]
Former [2007/13]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date07000411.419.12.2000
[2007/13]
Priority number, dateUS2000048862520.01.2000         Original published format: US 488625
[2007/13]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1767229
Date:28.03.2007
Language:EN
[2007/13]
Type: A3 Search report 
No.:EP1767229
Date:30.03.2011
[2011/13]
Type: B1 Patent specification 
No.:EP1767229
Date:16.08.2017
Language:EN
[2017/33]
Search report(s)(Supplementary) European search report - dispatched on:EP24.02.2011
ClassificationIPC:A61L27/16, A61L27/54, A61L31/04, A61L31/16, A61F2/06
[2011/13]
CPC:
A61L31/16 (EP,US); A61F2/06 (EP,US); A61L27/16 (EP,US);
A61L27/54 (EP,US); A61L31/048 (EP,US); A61F2250/0068 (EP,US);
A61L2300/00 (EP,US); A61L2300/416 (EP,US) (-)
C-Set:
A61L27/16, C08L27/18 (EP,US);
A61L31/048, C08L27/18 (US,EP)
Former IPC [2007/16]A61L27/16, A61L27/54, A61L31/04, A61L31/16
Former IPC [2007/13]A61L27/16
Designated contracting statesDE,   ES,   FR,   GB [2011/49]
Former [2007/13]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:Expandiertes PTFE Gefässtransplantat zur Arzneimittelabgabe[2007/16]
English:Expanded PTFE drug delivery graft[2007/13]
French:Greffon vasculaire en PTFE expansé pour l'administration des médicaments[2007/16]
Former [2007/13]Erweitertes PTFE-Arzneimittelabgabetransplantat
Former [2007/13]Greffe de distribution de médicaments étendue
Examination procedure22.09.2011Amendment by applicant (claims and/or description)
28.09.2011Examination requested  [2011/45]
01.10.2011Loss of particular rights, legal effect: designated state(s)
11.11.2011Despatch of communication of loss of particular rights: designated state(s) BE, IT
17.04.2015Despatch of a communication from the examining division (Time limit: M04)
25.08.2015Reply to a communication from the examining division
05.04.2017Communication of intention to grant the patent
06.07.2017Fee for grant paid
06.07.2017Fee for publishing/printing paid
06.07.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP00127283.0  / EP1121945
Divisional application(s)EP10184299.5  / EP2301592
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20000127283) is  23.12.2005
Opposition(s)17.05.2018No opposition filed within time limit [2018/30]
Fees paidRenewal fee
22.03.2007Renewal fee patent year 03
22.03.2007Renewal fee patent year 04
22.03.2007Renewal fee patent year 05
22.03.2007Renewal fee patent year 06
22.03.2007Renewal fee patent year 07
28.03.2008Renewal fee patent year 08
14.01.2008Renewal fee patent year 09
14.01.2009Renewal fee patent year 10
13.01.2011Renewal fee patent year 11
12.12.2011Renewal fee patent year 12
11.12.2012Renewal fee patent year 13
12.12.2013Renewal fee patent year 14
11.12.2014Renewal fee patent year 15
10.12.2015Renewal fee patent year 16
13.12.2016Renewal fee patent year 17
Penalty fee
Additional fee for renewal fee
31.12.200708   M06   Fee paid on   28.03.2008
31.12.201011   M06   Fee paid on   13.01.2011
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]US3797485  (URQUHART J) [I] 1-16 * figure -; claim - *;
 [A]WO9305730  (ATRIUM MEDICAL CORP [US]) [A] 1-16 * figure -; claim - *;
 [I]WO9823228  (ALZA CORP [US]) [I] 1-16 * figure -; claim - *;
 [A]US5795318  (WANG LIXIAO [US], et al) [A] 1-16* figure 1; claim - *;
 [I]US5891108  (LEONE JAMES E [US], et al) [I] 1-16 * the whole document *;
 [A]US5951458  (HASTINGS ROGER N [US], et al) [A] 1-16 * claim - *;
 [I]  - "DIRECTIONS FOR USE", ANNOUNCEMENT IMPRA,XX,XX, (1998), page COMPLETE, XP000945424 [I] 1-16 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.